Public trial registry of the CCC-Munich

Trial BO20999, GAUGUIN

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
BO20999, GAUGUIN
World
Full title
:

An open-label, multicentre, non-randomized, dose-escalatingphase I/II study, with a randomized phase II part, to investigate thesafety and tolerability of RO5072759 given as monotherapy inpatients with CD20+ malignant disease

World
EudraCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C85.- Sonstige und nicht näher bezeichnete Typen des Non-Hodgkin-Lymphoms
Trial design
World
Trial type
:
Interventional
World
Phase
:
I/II
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.